Biosenta Statistics

Total Valuation

Biosenta has a market cap or net worth of CAD 2.87 million. The enterprise value is 8.42 million.

Market Cap	2.87M
Enterprise Value	8.42M

Important Dates

The next estimated earnings date is Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	n/a

Share Statistics

Biosenta has 31.89 million shares outstanding. The number of shares has increased by 42.62% in one year.

Shares Outstanding	31.89M
Shares Change (YoY)	+42.62%
Shares Change (QoQ)	+4.74%
Owned by Insiders (%)	29.71%
Owned by Institutions (%)	6.86%
Float	16.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.63
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.25
EV / Sales	41.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.73

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-6.42
Interest Coverage	-1.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-217.26%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.69
Inventory Turnover	0.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.00% in the last 52 weeks. The beta is 0.34, so Biosenta's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	-75.00%
50-Day Moving Average	0.20
200-Day Moving Average	0.34
Relative Strength Index (RSI)	38.45
Average Volume (20 Days)	5,308

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biosenta had revenue of CAD 200,980 and -6.74 million in losses. Loss per share was -0.22.

Revenue	200,980
Gross Profit	200,449
Operating Income	-1.02M
Pretax Income	-6.74M
Net Income	-6.74M
EBITDA	n/a
EBIT	-1.02M
Loss Per Share	-0.22

Full Income Statement

Balance Sheet

The company has 6,302 in cash and 5.56 million in debt, giving a net cash position of -5.55 million or -0.17 per share.

Cash & Cash Equivalents	6,302
Total Debt	5.56M
Net Cash	-5.55M
Net Cash Per Share	-0.17
Equity (Book Value)	-7.17M
Book Value Per Share	-0.22
Working Capital	-1.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -849,979 and capital expenditures -15,559, giving a free cash flow of -865,538.

Operating Cash Flow	-849,979
Capital Expenditures	-15,559
Free Cash Flow	-865,538
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross Margin	99.74%
Operating Margin	-507.11%
Pretax Margin	-3,353.66%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-430.66%

Dividends & Yields

Biosenta does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.62%
Shareholder Yield	-42.62%
Earnings Yield	-246.04%
FCF Yield	-30.16%

Stock Splits

The last stock split was on June 28, 2016. It was a reverse split with a ratio of 0.0666666666.

Last Split Date	Jun 28, 2016
Split Type	Reverse
Split Ratio	0.0666666666

Scores

Biosenta has an Altman Z-Score of -112.01. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-112.01
Piotroski F-Score	n/a